Type 2 Diabetes Diagnosis Guidelines
Type 2 diabetes is diagnosed when any one of four criteria is met: fasting plasma glucose ≥126 mg/dL (after ≥8 hours fasting), 2-hour plasma glucose ≥200 mg/dL during a 75-g oral glucose tolerance test, HbA1c ≥6.5% (using NGSP-certified laboratory method), or random plasma glucose ≥200 mg/dL with classic hyperglycemic symptoms. 1
Diagnostic Thresholds
Primary Diagnostic Criteria
Any ONE of the following confirms diabetes:
- Fasting Plasma Glucose (FPG) ≥126 mg/dL (7.0 mmol/L) after at least 8 hours without caloric intake 2, 3, 1
- 2-hour Plasma Glucose ≥200 mg/dL (11.1 mmol/L) during a 75-g oral glucose tolerance test (OGTT) performed per WHO protocol 2, 3, 1
- HbA1c ≥6.5% measured in a laboratory using an NGSP-certified method standardized to the DCCT assay 2, 3, 1
- Random Plasma Glucose ≥200 mg/dL (11.1 mmol/L) in a patient with classic symptoms of hyperglycemia (polyuria, polydipsia, unexplained weight loss) 2, 3, 1
Confirmation Requirements
In the absence of unequivocal hyperglycemia with acute metabolic decompensation, abnormal results must be confirmed by repeat testing on a subsequent day. 2, 1
- If two different tests are both above diagnostic thresholds, diagnosis is confirmed 1
- If results are discordant between two different tests, repeat the test that exceeded the diagnostic threshold 1
- No confirmation is needed when a patient has classic hyperglycemic symptoms with random plasma glucose ≥200 mg/dL 3, 1
Prediabetes Criteria
Prediabetes is diagnosed when results fall within these ranges:
- FPG: 100-125 mg/dL (5.6-6.9 mmol/L) 2, 3, 1
- 2-hour OGTT: 140-199 mg/dL (7.8-11.0 mmol/L) 2, 3, 1
- HbA1c: 5.7-6.4% 2, 3, 1
Screening Guidelines for Adults
Who to Screen
Screen all adults aged 35 years and older, regardless of risk factors. 3 The American Diabetes Association updated this recommendation from age 45 to age 35 in recent guidelines. 3
Screen adults of any age with BMI ≥25 kg/m² (or ≥23 kg/m² in Asian Americans) who have one or more additional risk factors: 3, 1
- First-degree relative with diabetes 3
- High-risk race/ethnicity (Hispanic, American Indian/Alaska Native, Asian American, Black/African American, Native Hawaiian, Pacific Islander) 3
- History of cardiovascular disease 3
- Hypertension (≥140/90 mmHg or on antihypertensive therapy) 3
- HDL cholesterol <35 mg/dL and/or triglycerides >250 mg/dL 3
- Women with polycystic ovary syndrome 3
- Physical inactivity 3
- History of gestational diabetes 3, 1
Screening Frequency
- Repeat screening every 3 years if results are normal 3
- Screen annually in patients with prediabetes 2, 3
- Women with history of gestational diabetes require lifelong testing at least every 3 years 3
Test Selection and Practical Considerations
Preferred Testing Approach
FPG is the preferred initial test due to ease of administration, convenience, patient acceptability, and lower cost compared to OGTT. 1 Medicare reimbursement for FPG is $6 versus $19 for OGTT. 2
HbA1c offers the advantage of not requiring fasting, making it more convenient for patients. 2 However, it has lower sensitivity than glucose-based tests. 2
When NOT to Use HbA1c
Do not use HbA1c for diagnosis in conditions affecting red blood cell turnover: 2, 1
- Hemoglobinopathies (sickle cell disease, thalassemia) 2, 1
- Hemolytic anemias 2, 3, 1
- Pregnancy (second and third trimesters) 2, 3
- Recent blood loss or transfusion 2, 1
- Hemodialysis 2, 1
- Erythropoietin therapy 2, 1
In these conditions, use only plasma glucose criteria (FPG or OGTT). 2, 1
HbA1c Quality Requirements
- HbA1c must be performed in a laboratory using an NGSP-certified method 2, 1
- Point-of-care HbA1c testing should be used with caution for diagnosis, though it may be acceptable in CLIA-certified settings meeting quality standards 1
- Marked discordance between HbA1c and plasma glucose should raise suspicion for hemoglobin variants interfering with the assay 2, 1
Common Pitfalls and How to Avoid Them
Critical Diagnostic Errors
Do not rely on a single abnormal test without confirmation (except when random glucose ≥200 mg/dL with classic symptoms). 1 This is the most common diagnostic error—always confirm with repeat testing on a different day. 2
Do not use capillary blood glucose testing as a stand-alone diagnostic test—it performs poorly for diagnosis. 1
Recognize that type 2 diabetes frequently goes undiagnosed for many years because hyperglycemia develops gradually and may not initially cause symptoms. 3, 1 The duration of undiagnosed glycemic burden strongly predicts adverse outcomes. 3
Population-Specific Considerations
Do not overlook ethnic-specific BMI thresholds. Asian Americans have increased diabetes risk at BMI ≥23 kg/m² rather than ≥25 kg/m². 3, 1 Failing to apply this lower threshold leads to delayed diagnosis in this population.
Consider islet autoantibody testing in younger patients or those without traditional risk factors to exclude type 1 diabetes or latent autoimmune diabetes in adults (LADA). 3, 1 Up to 40% of adults with new type 1 diabetes are initially misdiagnosed as having type 2 diabetes. 1
Test Concordance Issues
Understand that FPG, 2-hour OGTT, and HbA1c do not necessarily detect diabetes in the same individuals—the concordance between these tests is imperfect. 2, 1 In high-risk individuals with FPG 100-125 mg/dL, nearly 50% may have diabetes by OGTT criteria. 4 This explains why confirmation testing is essential.